Search
Subscribe for $1
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Eli Lilly
Eli Lilly
Commentary
TrumpRx is here and it helps, though a bit less than advertised
By
Jeffrey Sonnenfeld
,
Stephen Henriques
,
Ferron Chen
,
Asuka Koda
and
Vanessa McLennan
February 11, 2026
Eli Lilly (LLY) Q4 2025 Earnings Call Transcript
By
Fortune Editors
February 4, 2026
Newsletters
Apple will use Google Gemini to power Siri
By
Andrew Nusca
January 13, 2026
Newsletters
Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
By
John Kell
November 19, 2025
Health
Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic
By
Nick Lichtenberg
November 6, 2025
Health
Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro
By
Matty Merritt
and
Morning Brew
October 31, 2025
Eli Lilly (LLY) Q3 2025 Earnings Call Transcript
By
Fortune Editors
October 30, 2025
Eli Lilly (LLY) Q2 2025 Earnings Call Transcript
By
Fortune Editors
August 7, 2025
Tech
Novo ousts CEO Jorgensen after Lilly competition hits shares
By
Eric Pfanner
and
Bloomberg
May 16, 2025
Health
Zepbound users lost nearly 50% more weight than those on Wegovy in first head-to-head study
By
Jonel Aleccia
and
The Associated Press
May 12, 2025
Eli Lilly (LLY) Q1 2025 Earnings Call Transcript
By
Fortune Editors
May 1, 2025
Politics
Viagra and Mounjaro panic-buying could be behind a 200% export surge from Ireland to the U.S.
By
Ryan Hogg
April 30, 2025
Retail
Novo Nordisk slides on pressure from Lilly’s pill study
By
Marthe Fourcade
and
Bloomberg
April 22, 2025
Retail
Roche, Zealand Pharma in $5.3 billion pact for obesity drugs
By
Paula Doenecke
,
Naomi Kresge
and
Bloomberg
March 12, 2025
Commentary
The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
By
Wendy Barnes
March 4, 2025
Most Popular
Middle East
Iran is now on 'death ground' amid existential threat from U.S. attacks and could 'go big' in retaliation, former NATO...
By
Jason Ma
Success
Japanese companies are paying older workers to sit by a window and do nothing—while Western CEOs demand super-AI...
By
Orianna Rosa Royle
AI
The week the AI scare turned real and America realized maybe it isn't ready for what's coming
By
Nick Lichtenberg